Increased maspin expression in cancer cells reportedly induces cell cycle arrest and apoptosis, promotes drug sensitivity, and inhibits HDAC1 activity, which play crucial roles in cancer progression and development [13,14]. This evidence concerns the gene HDAC1 and cancer.